Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

59.5K
Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
59.5K
Overview of Skeletal Muscle01:15

Overview of Skeletal Muscle

14.6K
Skeletal muscles are composed of a bundle of muscle fibers and are attached to bones through tendons. Each skeletal muscle fiber is a single muscle cell. The sarcolemma, the plasma membrane of a skeletal muscle cell, consists of a lipid bilayer and glycocalyx that supports muscle fibers. The sarcolemma extends into the muscle cells to form tubular structures called transverse or T-tubules. Each side of the T-tubules consists of a membrane-bound structure called the sarcoplasmic reticulum,...
14.6K
Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

5.9K
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
5.9K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.9K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.9K
Naming Skeletal Muscles01:19

Naming Skeletal Muscles

4.1K
The naming of the approximately 700 muscles in the human body is based on a set of criteria designed to provide descriptive information about each muscle, making it easier to identify and remember them.
The key factors used in naming muscles include:
4.1K
Skeletal Muscle Anatomy00:55

Skeletal Muscle Anatomy

92.8K
Skeletal muscle is the most abundant type of muscle in the body. Tendons are the connective tissue that attaches skeletal muscle to bones. Skeletal muscles pull on tendons, which in turn pull on bones to carry out voluntary movements.
92.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying Subclinical Transthyretin Cardiac Amyloidosis in V142I TTR Carriers: Design, Rationale, and Methods of the VISTA (Variant Imaging of Subclinical Transthyretin Amyloidosis) Study.

The American journal of cardiology·2026
Same author

Key Findings From the World Federation of Haemophilia National Member Organization Survey on Women and Girls With Bleeding Disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

A Rare Unusually Aggressive Form of Hereditary Transthyretin Amyloidosis.

JACC. Case reports·2025
Same author

Patient and Family Engagement in Australian and New Zealand Adult Critical Care Trials.

Annals of the American Thoracic Society·2025
Same author

The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases.

Neuro-oncology·2025
Same author

Salmonella Weltevreden lung abscess and empyema without preceding gastrointestinal symptoms: an emerging pathogen in Australia?

Access microbiology·2024
Same journal

Sotagliflozin improves cognitive deficits and attenuates neuroinflammation of Alzheimer's disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Neurological complications of current and emerging CAR-T cell therapies.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Hemodynamics Beyond Ischemic Zone Underlies Early Neurological Deterioration in Minor Stroke with Large Vessel Occlusion.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Nervonic acid and the long arc of therapeutic hope in X-linked adrenoleukodystrophy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Long-term efficacy of subthalamic nucleus deep brain stimulation in focal motor seizures and implications for candidate selection.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Brain interstitial fluid pharmacokinetics and therapeutic effect of a BBB penetrating amyloid beta antibody measured by microdialysis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
See all related articles

Related Experiment Video

Updated: Feb 3, 2026

Mitochondrial Isolation from Skeletal Muscle
09:45

Mitochondrial Isolation from Skeletal Muscle

Published on: March 30, 2011

29.6K

Skeletal Muscle Channelopathies.

Lauren Phillips1, Jaya R Trivedi2

  • 1Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas, 75390, USA.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|October 21, 2018
PubMed
Summary
This summary is machine-generated.

Skeletal muscle channelopathies are rare genetic disorders impacting quality of life. Advances in clinical trials offer hope for better diagnosis and treatment of these challenging conditions.

Keywords:
Channelopathieselectrophysiologyion channelnon-dystrophic myotoniaperiodic paralysis

More Related Videos

Adult and Embryonic Skeletal Muscle Microexplant Culture and Isolation of Skeletal Muscle Stem Cells
14:36

Adult and Embryonic Skeletal Muscle Microexplant Culture and Isolation of Skeletal Muscle Stem Cells

Published on: September 21, 2010

29.3K
Measurement of Protein Import Capacity of Skeletal Muscle Mitochondria
09:01

Measurement of Protein Import Capacity of Skeletal Muscle Mitochondria

Published on: January 7, 2022

3.0K

Related Experiment Videos

Last Updated: Feb 3, 2026

Mitochondrial Isolation from Skeletal Muscle
09:45

Mitochondrial Isolation from Skeletal Muscle

Published on: March 30, 2011

29.6K
Adult and Embryonic Skeletal Muscle Microexplant Culture and Isolation of Skeletal Muscle Stem Cells
14:36

Adult and Embryonic Skeletal Muscle Microexplant Culture and Isolation of Skeletal Muscle Stem Cells

Published on: September 21, 2010

29.3K
Measurement of Protein Import Capacity of Skeletal Muscle Mitochondria
09:01

Measurement of Protein Import Capacity of Skeletal Muscle Mitochondria

Published on: January 7, 2022

3.0K

Area of Science:

  • Neurology
  • Genetics
  • Rare Diseases

Background:

  • Skeletal muscle channelopathies are rare, heterogeneous disorders with significant genotypic and phenotypic variability.
  • These conditions lead to lifelong disability and reduced quality of life.
  • Diverse clinical manifestations pose challenges in diagnosis, treatment, genetic counseling, and research.

Purpose of the Study:

  • To highlight the challenges in diagnosing and managing skeletal muscle channelopathies.
  • To discuss the utility and limitations of electrodiagnostic and genetic testing.
  • To underscore the progress and potential of clinical research consortia in rare diseases.

Main Methods:

  • Review of current understanding of skeletal muscle channelopathies.
  • Discussion of diagnostic modalities including electrodiagnostic testing and genetic testing.
  • Analysis of recent clinical trial advancements in periodic paralysis and non-dystrophic myotonia.

Main Results:

  • Electrodiagnostic testing aids diagnosis but has limitations like patient discomfort and overlapping findings.
  • Genetic testing is the gold standard, yet mutations remain unidentified in some clinically diagnosed cases.
  • Recent clinical trials demonstrate the feasibility of well-controlled rare disease research.

Conclusions:

  • Despite diagnostic challenges, advances in understanding and research offer improved prospects for patients.
  • Clinical research consortia are crucial for advancing therapeutic strategies for rare muscle channelopathies.
  • Continued research is vital for addressing the unmet needs in skeletal muscle channelopathies.